A newly developed anti-Mucin 13 monoclonal antibody targets pancreatic ductal adenocarcinoma cells.

Nishii Y, Yamaguchi M, Kimura Y, Hasegawa T, Aburatani H, Uchida H, Hirata K, Sakuma Y.Int. J. Oncol. 2015 Apr;46(4):1781-7. doi: 10.3892/ijo.2015.2880